ImmunityBio (IBRX) Non-Current Assets (2014 - 2026)
ImmunityBio (IBRX) reported Non-Current Assets of $189.52 million for Q2 2026, down 2.3% from $193.94 million a year earlier and down 2.1% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio posted Non-Current Assets of $187.02 million, down 5.7% from FY2024.
- Non-Current Assets has declined for three consecutive years, though with a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $198.35 million in FY2024 (-5.7%), $210.37 million in FY2023 (-5.1%), $221.78 million in FY2022 (+64.8%) and $134.56 million in FY2021 (+22.7%).
- Five-year quarterly Non-Current Assets spans a low of $119.97 million in Q3 2021 and a high of $229.91 million in Q1 2023.
- Year over year, Non-Current Assets has now declined in each of the last 11 quarters, with an average decline of 4.5% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q3 2022 (growth of 74.9%); the low point was Q1 2024 (a decline of 10.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $193.68 million (Q1 2026), $187.02 million (Q4 2025) and $189.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | ImmunityBio | 7.48 Bn | 6.24 Bn | 50.94 Mn | 189.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.52 Mn |
| Mar 31, 2026 | 193.68 Mn |
| Dec 31, 2025 | 187.02 Mn |
| Sep 30, 2025 | 189.49 Mn |
| Jun 30, 2025 | 193.94 Mn |
| Mar 31, 2025 | 194.60 Mn |
| Dec 31, 2024 | 198.35 Mn |
| Sep 30, 2024 | 201.42 Mn |
| Jun 30, 2024 | 201.50 Mn |
| Mar 31, 2024 | 204.96 Mn |
| Dec 31, 2023 | 210.37 Mn |
| Sep 30, 2023 | 217.34 Mn |
| Jun 30, 2023 | 224.40 Mn |
| Mar 31, 2023 | 229.91 Mn |
| Dec 31, 2022 | 221.78 Mn |
| Sep 30, 2022 | 209.85 Mn |
| Jun 30, 2022 | 202.73 Mn |
| Mar 31, 2022 | 177.25 Mn |
| Dec 31, 2021 | 134.56 Mn |
| Sep 30, 2021 | 119.97 Mn |
API Access
ImmunityBio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();